Search for: "In re Cipro Cases I & II" Results 1 - 20 of 24
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Mar 2015, 4:00 am by Kimberly A. Kralowec
On Tuesday, March 3, 2015, I attended the oral argument in In re Cipro Cases I & II, No. [read post]
3 Mar 2015, 4:00 am by Kimberly A. Kralowec
This morning at 9:00 a.m. in San Francisco, the Court will hear oral argument in In re Cipro Cases I & II, No. [read post]
17 Feb 2015, 4:00 am by Kimberly A. Kralowec
  On March 3, 2015 at 9:00 a.m. in San Francisco, the Court will hear argument in In re Cipro Cases I & II, No. [read post]
2 Nov 2011, 5:00 am by Kimberly A. Kralowec
In In re Cipro Cases I & II, ___ Cal.App.4th ___ (Nov. 1, 2011), the Court of Appeal (Fourth Appellate District, Division One) followed Chavez v. [read post]
8 May 2015, 4:00 am by Kimberly A. Kralowec
Yesterday, the Supreme Court handed down its eagerly-anticipated opinion, In re Cipro Cases I & II, __ Cal.4th ___ (May 7, 2015), in which the Court was expected to reaffirm its landmark holding in Cel-Tech that conduct can be "unfair" under the UCL even if not "unlawful," and vice versa. [read post]
11 May 2015, 10:00 pm by Courtenay C. Brinckerhoff
In In Re Cipro Cases I & II, the California Supreme Court laid out a four-part rule of reason analysis for evaluating ANDA settlements that involve a reverse payment to the generic challenger (also referred to as “pay for delay” settlements). [read post]
20 May 2010, 7:30 am by FDABlog HPM
  The case, In re: Cipro Cases I & II, is a proceeding of nine coordinated cases brought by indirect CIPRO purchasers almost ten years ago. [read post]
1 Nov 2011, 6:12 pm by FDABlog HPM
The case, styled as In re Cipro Cases I & II, was initiated in late 2000 and is a proceeding of nine coordinated cases brought by indirect CIPRO purchasers. [read post]
17 Dec 2009, 7:02 am by Matt C. Bailey
(citing In re Cipro Cases I & II, 121 Cal.App.4th 402, 418 (2004).While each of these defects may have been resolved by redefining the class [Hicks v. [read post]
20 Aug 2013, 5:00 am by Kimberly A. Kralowec
Valencia Holding Co., LLC, 201 Cal.App.4th 74 (2011) In re Cipro Cases I & II, no. [read post]
17 Feb 2012, 4:19 pm by The Complex Litigator
  Notable results include: On a petition for review, review was granted in In re Cipro Cases I & II. [read post]
13 Sep 2012, 4:26 pm by Brad Pauley
Supreme Court’s Resolution of Related Case In re Cipro Cases I & II, S198616—Briefing Stayed—September 12, 2012 The question presented is whether an action under the Cartwright Antitrust Act (Bus. [read post]
18 Feb 2012, 8:27 pm by Brad Pauley
In re Cipro Cases I & II, S198616—Review Granted—February 15, 2012  The question presented is whether a suit may be brought under the Cartwright Antitrust Act to challenge “reverse exclusionary payments” made by pharmaceutical manufacturers to settle patent litigation with generic drug producers and prolong the life of the patents in question. [read post]
17 Oct 2013, 5:00 am by Kimberly A. Kralowec
  They and I have had several preparatory calls, and I have already learned some facsinating things about the practical aspects of taking a class action case to trial in the post-Dukes and post-Duran world. [read post]
29 Aug 2012, 10:09 pm by FDABlog HPM
  As we previously reported, the case, styled as In re Cipro Cases I & II, was initiated in late 2000 and is a proceeding of nine coordinated cases brought by indirect CIPRO purchasers. [read post]
12 Feb 2024, 6:00 am by Daniel J. Gilman
And while we’re at it, comments to NIST from intellectual-property experts (here and here) and additional comments from Alden (here). [read post]